Abnormal striatal expression of transcripts encoding NMDA interacting PSD proteins in schizophrenia, bipolar disorder and major depression

Schizophrenia Research

Volumn 78, Issue 1, 2005, Pages 87-93

  Kristiansen, Lars V ^a   Meador Woodruff, James H ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Basal ganglia; Glutamate; In situ hybridization; N methyl D aspartate; Postsynaptic; Striatum

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROFILAMENT PROTEIN; POSTSYNAPTIC DENSITY PROTEIN 93; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN; SYNAPSE ASSOCIATED PROTEIN 102; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOPSY; BIPOLAR DEPRESSION; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MEMBRANE; MENTAL PATIENT; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; SCHIZOPHRENIA; SYNAPSE;

ADULT; AGED; ALTERNATIVE SPLICING; BASAL GANGLIA; BIPOLAR DISORDER; BRAIN; BRAIN MAPPING; CEREBRAL CORTEX; CORPUS STRIATUM; DEPRESSIVE DISORDER, MAJOR; FEMALE; GLUTAMATES; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NEURAL PATHWAYS; RECEPTORS, N-METHYL-D-ASPARTATE; REFERENCE VALUES; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; STATISTICS; THALAMUS;

EID: 23944505476     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2005.06.012     Document Type: Article

References (31)

1. S. Akbarian, N.J. Sucher, D. Bradley, A. Tafazzoli, D. Trinh, W.P. Hetrick, S.G. Potkin, C.A. Sandman, W.E. Bunney Jr., and E.G. Jones Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics J. Neurosci. 16 1996 19 30
2. B. Belsham Glutamate and its role in psychiatric illness Hum. Psychopharmacol. 16 2001 139 146
3. H.J. Chung, Y.H. Huang, L.F. Lau, and R.L. Huganir Regulation of the NMDA receptor complex and trafficking by activity-dependent phosphorylation of the NR2B subunit PDZ ligand J. Neurosci. 24 2004 10248 10259
4. S.M. Clinton, and J.H. Meador-Woodruff Abnormalities of the NMDA receptor and associated intracellular molecules in the thalamus in schizophrenia and bipolar disorder Neuropsychopharmacology 29 2004 1353 1362
5. S.M. Clinton, S. Abelson, V. Haroutunian, K.L. Davis, and J.H. Meador-Woodruff Neurofilament subunit protein abnormalities in the thalamus in schizophrenia Thalamus Relat. Syst. 2 2004 265 272
6. J.T. Coyle The GABA-glutamate connection in schizophrenia: which is the proximate cause? Biochem. Pharmacol. 68 2004 1507 1514
7. N. Craddock, M.C. O'Donovan, and M.J. Owen The genetics of schizophrenia and bipolar disorder: dissecting psychosis J. Med. Genet. 42 2005 193 204
8. A. Fujita, and Y. Kurachi SAP family proteins Biochem. Biophys. Res. Commun. 269 2000 1 6
9. D. Godreau, N. Neyroud, R. Vranckx, and S. Hatem MAGUKs: not only anchoring proteins Med. Sci. (Paris) 20 2004 84 88
10. T. Iwamoto, Y. Yamada, K. Hori, Y. Watanabe, K. Sobue, and M. Inui Differential modulation of NR1-NR2A and NR1-NR2B subtypes of NMDA receptor by PDZ domain-containing proteins J. Neurochem. 89 2004 100 108
11. J.S. Kim Transmitters for the afferent and efferent systems of the neostriatum and their possible interactions Adv. Biochem. Psychopharmacol. 19 1978 217 233
12. E. Kravariti, T. Dixon, C. Frith, R. Murray, and P. McGuire Association of symptoms and executive function in schizophrenia and bipolar disorder Schizophr. Res. 74 2005 221 231
13. B. Li, Y. Otsu, T.H. Murphy, and L.A. Raymond Developmental decrease in NMDA receptor desensitization associated with shift to synapse and interaction with postsynaptic density-95 J. Neurosci. 23 2003 11244 11254
14. D.R. Lynch, and R.P. Guttmann NMDA receptor pharmacology: perspectives from molecular biology Curr. Drug Targets 2 2001 215 231
15. J.H. Meador-Woodruff, A.J. Hogg Jr., and R.E. Smith Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder Brain Res. Bull. 55 2001 631 640
16. J.H. Meador-Woodruff, S.M. Clinton, M. Beneyto, and R.E. McCullumsmith Molecular abnormalities of the glutamate synapse in the thalamus in schizophrenia Ann. N.Y. Acad. Sci. 1003 2003 75 93
17. J.B. Murray Phencyclidine (PCP): a dangerous drug, but useful in schizophrenia research J. Psychol. 136 2002 319 327
18. S. Naisbitt, J. Valtschanoff, D.W. Allison, C. Sala, E. Kim, A.M. Craig, R.J. Weinberg, and M. Sheng Interaction of the postsynaptic density-95/guanylate kinase domain-associated protein complex with a light chain of myosin-V and dynein J. Neurosci. 20 2000 4524 4534
19. I. Perez-Otano, and M.D. Ehlers Learning from NMDA receptor trafficking: clues to the development and maturation of glutamatergic synapses Neurosignals 13 2004 175 189
20. J. Ratnam, and V.I. Teichberg Neurofilament-light increases the cell surface expression of the N-methyl-d-aspartate receptor and prevents its ubiquitination J. Neurochem. 92 2005 878 885
21. R.C. Roberts, J.K. Roche, and R.R. Conley Synaptic differences in the postmortem striatum of subjects with schizophrenia: a stereological ultrastructural analysis Synapse 56 2005 185 197
22. K.W. Roche, S. Standley, J. McCallum, C. Dune Ly, M.D. Ehlers, and R.J. Wenthold Molecular determinants of NMDA receptor internalization Nat. Neurosci. 4 2001 794 802
23. N. Sans, K. Prybylowski, R.S. Petralia, K. Chang, Y.X. Wang, C. Racca, S. Vicini, and R.J. Wenthold NMDA receptor trafficking through an interaction between PDZ proteins and the exocyst complex Nat. Cell Biol. 5 2003 520 530
24. H.H. Schiffer Glutamate receptor genes: susceptibility factors in schizophrenia and depressive disorders? Mol. Neurobiol. 25 2002 191 212
25. M. Sheng, and D.T. Pak Glutamate receptor anchoring proteins and the molecular organization of excitatory synapses Ann. N.Y. Acad. Sci. 868 1999 483 493
26. Y. Smith, D.V. Raju, J.F. Pare, and M. Sidibe The thalamostriatal system: a highly specific network of the basal ganglia circuitry Trends Neurosci. 27 2004 520 527
27. Y.X. Tao, G. Rumbaugh, G.D. Wang, R.S. Petralia, C. Zhao, F.W. Kauer, F. Tao, M. Zhuo, R.J. Wenthold, S.N. Raja, R.L. Huganir, D.S. Bredt, and R.A. Johns Impaired NMDA receptor-mediated postsynaptic function and blunted NMDA receptor-dependent persistent pain in mice lacking postsynaptic density-93 protein J. Neurosci. 23 2003 6703 6712
28. E.F. Torrey, M. Webster, M. Knable, N. Johnston, and R.H. Yolken The Stanley Foundation brain collection and neuropathology consortium Schizophr. Res. 44 2000 151 155
29. G. Tsai, and J.T. Coyle Glutamatergic mechanisms in schizophrenia Annu. Rev. Pharmacol. Toxicol. 42 2002 165 179
30. R.J. Wenthold, K. Prybylowski, S. Standley, N. Sans, and R.S. Petralia Trafficking of NMDA receptors Annu. Rev. Pharmacol. Toxicol. 43 2003 335 358
31. M.J. Zigmond, S.L. Castro, K.A. Keefe, E.D. Abercrombie, and A.F. Sved Role of excitatory amino acids in the regulation of dopamine synthesis and release in the neostriatum Amino Acids 14 1998 57 62